Annual Report · 10-K
Rigel Pharmaceuticals, Inc.
RIGLNASDAQEQUITYCurrent
Annual Report
Company context
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗